UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7426
Vesta Real Estate
VTMX
$3.12B
| $16.1K | ﹤0.01% |
538
+536
| +26,800% | +$18.7K |
|
7427
Gogoro
GGR
$53.8M
| $16.1K | ﹤0.01% |
+523
| New | +$16.1K |
|
|
SIFY
7428
Sify Technologies
SIFY
$1.14B
| $16.1K | ﹤0.01% |
6,104
+6,096
| +76,200% | +$38.8K |
|
7429
Mangoceuticals
MGRX
$7.3M
| $16.1K | ﹤0.01% |
3,530
+2,567
| +267% | +$11.9K |
|
7430
Soligenix
SNGX
$5.68M
| $16.1K | ﹤0.01% |
6,231
+6,142
| +6,901% | +$35.4K |
|
7431
Hanover Bancorp
HNVR
$194M
| $16K | ﹤0.01% |
971
+916
| +1,665% | +$14.7K |
|
|
VHAI
7432
DELISTED
Vocodia Holdings Corp.
VHAI
| $16K | ﹤0.01% |
+225,015
| New | +$42.9K |
|
7433
Intelligent Bio Solutions
INBS
$4.28M
| $16K | ﹤0.01% |
832
+797
| +2,277% | +$20.4K |
|
|
BCIC
7434
BCP Investment Corp
BCIC
$90.9M
| $15.9K | ﹤0.01% |
812
+100
| +14% | +$1.94K |
|
|
AC
7435
DELISTED
Associated Capital Group
AC
| $15.9K | ﹤0.01% |
468
+12
| +3% | +$400 |
|
7436
FT Vest Growth-100 Buffer ETF March
QMAR
$575M
| $15.9K | ﹤0.01% |
568
-4,709
| -89% | -$126K |
|
7437
FT Vest US Equity Deep Buffer ETF July
DJUL
$450M
| $15.9K | ﹤0.01% |
399
-2,642
| -87% | -$103K |
|
|
AIIO
7438
Robo.ai Inc
AIIO
$497M
| $15.8K | ﹤0.01% |
618
+347
| +128% | +$31.3K |
|
7439
NextCure
NXTC
$21.4M
| $15.8K | ﹤0.01% |
827
-74
| -8% | -$1.44K |
|
|
CLYM
7440
Climb Bio
CLYM
$714M
| $15.8K | ﹤0.01% |
2,218
-3,707
| -63% | -$24.7K |
|
7441
ProShares Hedge Replication ETF
HDG
$22.2M
| $15.7K | ﹤0.01% |
+321
| New | +$15.8K |
|
|
JVSAU
7442
DELISTED
JVSPAC Acquisition Corp. Unit
JVSAU
| $15.7K | ﹤0.01% |
+1,500
| New | +$15.6K |
|
|
IMOS
7443
ChipMOS TECHNOLOGIES
IMOS
$1.77B
| $15.6K | ﹤0.01% |
599
-401
| -40% | -$11.2K |
|
7444
AtlasClear
ATCH
$26.6M
| $15.6K | ﹤0.01% |
250
+242
| +3,025% | +$16.7K |
|
7445
Amtech Systems
ASYS
$280M
| $15.6K | ﹤0.01% |
2,665
-4,786
| -64% | -$25.8K |
|
7446
Regis Corp
RGS
$68.6M
| $15.6K | ﹤0.01% |
679
-382
| -36% | -$2.53K |
|
7447
Aptus Behavioral Momentum ETF
ADME
$303M
| $15.6K | ﹤0.01% |
357
+227
| +175% | +$9.53K |
|
7448
OFS Capital
OFS
$48M
| $15.5K | ﹤0.01% |
1,752
-1,933
| -52% | -$18.6K |
|
7449
Rezolute
RZLT
$451M
| $15.5K | ﹤0.01% |
+3,614
| New | +$12.4K |
|
|
NBTX
7450
Nanobiotix
NBTX
$2.02B
| $15.5K | ﹤0.01% |
3,100
| – | – |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.